Winthrop P. Rockefeller Cancer Institute: UAMS Performs First GammaTile Brain Surgery in Arkansas
LITTLE ROCK — Radiation oncologist Richard Crownover, M.D., Ph.D., and neurosurgeon Analiz Rodriguez, M.D., Ph.D., and their care team at the University of Arkansas for Medical Sciences (UAMS) have performed the state’s first application of GammaTile Therapy.
Cancer Discovery Published in Nature Highlights National Role of UAMS Research Team
LITTLE ROCK — A highly specialized UAMS research team that serves as a national resource recently helped the University of North Carolina (UNC) discover a key driver of cancer cell development. The discovery, which gives researchers around the globe a new target for drug therapies, was published in the journal Nature. The achievement put an…Read more
Michael Birrer, M.D., Ph.D., Invested in Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute
LITTLE ROCK — Michael Birrer, M.D., Ph.D., vice chancellor and director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), was invested July 15 in the Kent C. Westbrook, M.D. Director’s Chair for the Winthrop P. Rockefeller Cancer Institute. “Michael Birrer’s scholarly corpus is incredibly impressive, and the…Read more
Winthrop P. Rockefeller Cancer Institute Hosts First Summer Research Intensive for Medical Students
New discoveries in cancer treatment might come from 24-year-old Nadia Safar, one of 12 UAMS medical students participating in the state’s first and only undergraduate cancer research program at the Winthrop P. Rockefeller Cancer Institute.Read more
UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer
LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…Read more
Want to read more stories like these?